Darbepoetin alfa biosimilar - Dr Reddy's

Drug Profile

Darbepoetin alfa biosimilar - Dr Reddy's

Alternative Names: Cresp

Latest Information Update: 30 Aug 2016

Price : $50

At a glance

  • Originator Dr Reddys Laboratories
  • Class Antianaemics; Recombinant erythropoietins
  • Mechanism of Action Erythropoiesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Anaemia

Most Recent Events

  • 29 Apr 2016 Biomarkers information updated
  • 31 Dec 2010 Launched during 2010 for Anaemia (chemotherapy-induced) in India (SC)
  • 31 Dec 2010 Launched during 2010 for Anaemia in India (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top